Chengdu Shengnuo Biopharm Co.,Ltd. founded in 2004, is located in Chengdu, China. Four main business ares are peptide APIs, cosmetic peptides,CDMO services and peptide FDF. The facility has been inspected by the US-FDA four times. 10 products have been registered in US-FDA: Semaglutide, Liraglutide,Icatibant Aceate, Eptifibaitde, Bivalirudin, Octreotide Acetate, linaclotide, Teriparatide, Ganirelix, Ziconotide Acetate.